MesDA Progenitor Cell Profiling by Flow Cytometry for Engraftment Prediction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for analyzing the protein expression of dopaminergic progenitor cells are limited by mRNA-based techniques that are time-consuming, prone to contamination, and lack sensitivity and discriminatory power to predict successful cell grafting and engraftment, particularly in the context of Parkinson's disease treatment.
Innovation Solution
A method utilizing antigen binding molecules, such as antibody-fluorochrome conjugates, for single-cell protein profiling of floorplate mesDA progenitor cells through flow cytometry, allowing for a standardized and quantitative assessment of specific markers like FOXA2, OTX2, CD47, NKX2.1, OCT3/4, PAX6, SOX1, NKX6.1, and KI-67, to ensure cell identity and purity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If bulk mRNA analysis is used to analyze protein expression in floorplate mesencephalic dopaminergic progenitor cells, then the analysis can be performed using conventional methods, but the results are not predictive of protein presence and do not provide clear quantitative description of cellular phenotypes
Solution Approach 1:
The patent replaces conventional bulk mRNA analysis methods with flow cytometry-based single-cell protein profiling. This substitution transitions from indirect molecular analysis to direct protein detection, providing accurate quantitative measurement of cellular phenotypes and reliable prediction of protein presence through direct antigen-antibody interactions detected by flow cytometry
Solution Approach 2:
The patent segments the bulk cell population analysis into single-cell level analysis. By profiling protein expression at the individual cell level rather than averaging across populations, the method provides clear quantitative description of cellular phenotypes and identifies heterogeneous cell states that bulk analysis would mask
2Measurement precision
If standardized flow cytometry assays are implemented for single-cell protein profiling, then quantitative and clear cellular phenotype description is achieved, but the method complexity and standardization requirements increase
Solution Approach 1:
The patent develops a universal flow cytometry assay platform that can profile multiple protein markers (FOXA2, OTX2, NKX2.1, NKX6.1, and other dopaminergic markers) simultaneously using a standardized protocol. This multi-functional approach allows the same methodology to be applied across different cell types and differentiation stages, reducing overall complexity through standardization while maintaining high measurement precision
Solution Approach 2:
The patent optimizes flow cytometry assay parameters including antibody concentrations, incubation times, and instrument settings to achieve standardized, reproducible results. By establishing fixed parameter ranges and quality control thresholds, the method transforms a potentially complex procedure into a routine standardized assay that maintains high precision without requiring excessive operational complexity
3Loss of information
If multiple protein markers are analyzed simultaneously by flow cytometry, then comprehensive cellular phenotype characterization is achieved, but the analysis time and resource requirements increase
Solution Approach 1:
The patent combines the analysis of multiple protein markers (FOXA2, OTX2, NKX2.1, NKX6.1, and dopaminergic markers) into a single flow cytometry assay. By using multi-color flow cytometry to detect multiple antigens simultaneously on the same cell population, the method achieves comprehensive cellular phenotype characterization without requiring sequential assays, thereby minimizing time loss while maximizing information completeness
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid, reliable identification of floorplate mesDA progenitor cells with high sensitivity, ensuring their potential for successful engraftment and functional re-innervation in Parkinson's disease therapy.
Implementation Method 1
contacting the cells of said cell composition or the cells of a sample thereof with antigen binding molecules specific for the antigens FOXA2, OTX2, PAX6, and NKX6.1, thereby labeling the cells
Data Source
AI summary
This disclosure provides a method and kit for analyzing compositions of human floorplate mesencephalic dopaminergic (mesDA) progenitor cells that are obtained, for example, by differentiating embryonic stem cells. The mesDA progenitors are characterized using the positive markers FOXA2. OTX2, and optionally NKX2. 1. in combination with the negative markers OCT3/4, and optionally PAX6, and SOXI. Cells with an appropriate protein expression profile have therapeutic potential for restoring the function of dopaminergic neurons in conditions such as Parkinson's Disease.